Mangoceuticals (MGRX) Other Operating Expenses (2023 - 2026)

Mangoceuticals' Other Operating Expenses history runs 4 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 32.13% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $13.3 million (up 97.7% YoY), while the FY2025 annual figure was -$125624.0, down 102.35% from the prior year.
• Other Operating Expenses came in at $2.1 million for Q1 2026 at Mangoceuticals, up from -$241976.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $7.3 million in Q3 2025 to a low of -$241976.0 in Q4 2025.
• A 4-year average of $2.3 million and a median of $1.8 million in 2023 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 453.0% in 2025 and fell as far as 126.78% in 2025.
• Mangoceuticals' Other Operating Expenses stood at $1.9 million in 2023, then sank by 52.13% to $903710.0 in 2024, then tumbled by 126.78% to -$241976.0 in 2025, then surged by 968.35% to $2.1 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $2.1 million, -$241976.0, and $7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison